30
Sep 2026
Among cancer patients who received personalized support and navigation services from experts throughout the genetic testing process, their first-degree relatives – parents, siblings and children – were significantly more likely to receive genetic testing, as well.
30
Sep 2026
Researchers with Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have created a framework for developing, evaluating and implementing AI tools in cancer survivorship and supportive care, according to a new proof-of-concept study published in the journal Translational Behavioral Medicine.
30
Sep 2026
Researchers from Mass General Brigham and the University of Cyprus have developed a sophisticated mathematical model to better understand how the tumor microenvironment affects the delivery and effectiveness of a new type of cancer therapy called an immunomodulatory antibody-drug conjugate (IM-ADC).
30
Sep 2026
Young adults who use generative artificial intelligence to ask health-related questions are more likely to screen positive for clinically significant anxiety and depression than those not using the AI tool for health issues, according to a new study led by University of Florida researcher Yusen Zhai.
30
Sep 2026
Mayo Clinic researchers led a multicenter study that found dividing radiation into several treatments, known as fractionated stereotactic radiosurgery, reduced the risk of cancer returning after surgery for brain metastases and was associated with improved survival compared with delivering radiation in a single treatment.
30
Sep 2026
Laverock Therapeutics (‘Laverock’), a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announces its in vivo programs spanning CAR-T and genetic medicine
30
Sep 2026
Probiotic supplementation in very preterm infants is linked to lower rates of necrotizing enterocolitis and mortality, according to a nationwide Swedish study.
30
Sep 2026
Early smartphone use is linked to a rise in eating disorder symptoms among adolescents, indicating potential mental health implications that require attention.
30
Sep 2026
INTEGRA's automated solutions optimize CRISPR workflows, enhancing gene editing efficiency and accelerating the path to innovative therapeutic developments.
30
Sep 2026
Mouser Electronics, Inc., an authorized global distributor with the widest selection of semiconductors and electronic components, is shipping a wide array of new products and solutions from the YAGEO Group, a leading global passive component manufacturer.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
